# Nevada ePro #41NHA-S4034

RFI for Medicaid Pharmaceutical Data and Retrospective Pricing Analytics SaaS

**Posted:** September 30, 2026
**Respond By:** October 29, 2026
**Identifier:** 41NHA-S4034
**NAICS:** 513210, 541512

The Nevada Health Authority is gathering information on a SaaS platform to support Medicaid prescription-drug analytics and preferred drug list decisions.
- **Government buyer:** Nevada Health Authority; Nevada Medicaid – Prescription Drug Rebate. No specific office is identified.
- **Opportunity type:** Informational-only RFI seeking platform information and projected costs; it is not a request for bids or proposals and does not anticipate a contract award.
- **Requested service:** Pharmaceutical data and retrospective pricing analytics SaaS to support single preferred drug list management, fiscal forecasting, formulary and clinical strategy, and contracting and market-access decisions.
- **Requested capabilities:** Track drug and biologic lifecycles, brand/generic/biosimilar launches, loss of exclusivity, clinical pipelines, litigation, and regulatory impacts; provide market and clinical reports, alerts, new-drug reviews, expert consultation, and pricing and financial forecasts; validate HCPCS/CPT drug codes and provide coding, billing, and reimbursement information.
- **Notable requirements:** Support Medicaid-focused analysis, transparent forecast inputs, catalyst alerts, scorecards, analogs, and expert commentary, with web access available around the clock.
- **OEMs and vendors:** No OEM, software product, or vendor is named in the opportunity documents.
- **Service line classifications:** Three SaaS service lines are listed, each with a quantity of 1, under NIGP 920-03, 920-45, and 208-57.

### Description

This is a Request for Information (RFI) for a SaaS platform providing pharmaceutical data and retrospective pricing analytics for Nevada Health Authority, Medicaid - Prescription Drug Rebate. The platform is described as combining pharmaceutical market, clinical pipeline, pricing, and medical/pharmacy benefit information to support preferred drug list management, forecasting, and formulary, clinical, contracting, and market-access decisions. Requested capabilities include drug and biologic lifecycle tracking, loss-of-exclusivity and launch insights, clinical and pricing reports, alerts, forecasts, and drug-code validation. Vendors are asked to provide projected costs; this RFI is informational only and will not result in a contract award.

[View original listing](https://nevadaepro.com/bso/external/bidDetail.sda?docId=41NHA-S4034&external=true&parentUrl=close)